Literature DB >> 22776830

Fetal presentation of long QT syndrome--evaluation of prenatal risk factors: a systematic review.

Satoshi Ishikawa1, Takashi Yamada, Tomoyuki Kuwata, Mamoru Morikawa, Takahiro Yamada, Shigeki Matsubara, Hisanori Minakami.   

Abstract

OBJECTIVE: This systematic review evaluated the existence of risk factors for the fetal manifestation of long QT syndrome (LQTS).
METHODS: Prenatal cardiac findings suggestive of fetal LQTS were studied using 30 English literature reports extracted from the Pubmed database (1979 to December 2011) using the search terms 'long QT syndrome', 'fetal arrhythmia' and 'congenital heart disease'.
RESULTS: LQTS accounted for 15-17% of fetal bradycardias <110 bpm among fetuses with a normally structured heart. Of the patients with significant prenatal findings of LQTS, 17-35% exhibited a reduced baseline fetal heart rate (FHR) of 110-120 bpm on electronic cardiotocography. Other prenatal signs were sinus or intermittent bradycardia <110 bpm arising from atrioventricular block, tachyarrhythmias, pleural effusion and hydrops. More than 30% of Japanese infants with LQTS born at or after the mid-1980s exhibited the above-mentioned in utero signs.
CONCLUSIONS: Fetal factors including a slightly reduced baseline FHR of 110-120 bpm, bradycardia <110 bpm, tachyarrhythmias or clinical signs of heart failure, such as pleural effusion and hydrops, were associated with a higher frequency of LQTS. The use of these signs may help to increase the perinatal diagnosis of LQTS.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22776830     DOI: 10.1159/000339150

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  7 in total

1.  Noninvasive Fetal Electrocardiography in the Diagnosis of Long QT Syndrome: A Case Series.

Authors:  Neeta Sethi; Kiyoe Funamoto; Catherine Ingbar; Paige Mass; Jeffrey Moak; Ronald Wakai; Janette Strasburger; Mary Donofrio; Ahsan Khandoker; Yoshitaka Kimura; Anita Krishnan
Journal:  Fetal Diagn Ther       Date:  2020-07-02       Impact factor: 2.587

2.  Congenital long QT syndrome: A challenging diagnosis by fetal echocardiography.

Authors:  Aura Daniella Santi; Miguel Restrepo
Journal:  Ann Pediatr Cardiol       Date:  2022-06-14

3.  Long QT syndrome-associated mutations in intrauterine fetal death.

Authors:  Lia Crotti; David J Tester; Wendy M White; Daniel C Bartos; Roberto Insolia; Alessandra Besana; Jennifer D Kunic; Melissa L Will; Ellyn J Velasco; Jennifer J Bair; Alice Ghidoni; Irene Cetin; Daniel L Van Dyke; Myra J Wick; Brian Brost; Brian P Delisle; Fabio Facchinetti; Alfred L George; Peter J Schwartz; Michael J Ackerman
Journal:  JAMA       Date:  2013-04-10       Impact factor: 56.272

4.  Successful prenatal management of ventricular tachycardia and second-degree atrioventricular block in fetal long QT syndrome.

Authors:  Akira Miyake; Heima Sakaguchi; Aya Miyazaki; Takekazu Miyoshi; Takeshi Aiba; Isao Shiraishi
Journal:  HeartRhythm Case Rep       Date:  2016-09-21

5.  Fetal heart rate reflects mutation burden and clinical outcome in twin probands with KCNQ1 mutations.

Authors:  Annika Winbo; Annika Rydberg
Journal:  HeartRhythm Case Rep       Date:  2018-04-05

6.  Identification of putative pathogenic single nucleotide variants (SNVs) in genes associated with heart disease in 290 cases of stillbirth.

Authors:  Ellika Sahlin; Anna Gréen; Peter Gustavsson; Agne Liedén; Magnus Nordenskjöld; Nikos Papadogiannakis; Karin Pettersson; Daniel Nilsson; Jon Jonasson; Erik Iwarsson
Journal:  PLoS One       Date:  2019-01-07       Impact factor: 3.240

7.  A missense mutation of ErbB2 produces a novel mouse model of stillbirth associated with a cardiac abnormality but lacking abnormalities of placental structure.

Authors:  Heba Shawer; Esther Aiyelaagbe; Christopher Clowes; Samantha C Lean; Yinhui Lu; Karl E Kadler; Alan Kerby; Mark R Dilworth; Kathryn E Hentges; Alexander E P Heazell
Journal:  PLoS One       Date:  2020-06-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.